About NATSpert
NATSpert is a company based in Pune (India) founded in 2017. It operates as a B2B and D2C. The company has 437 employees as of March 31, 2022. NATSpert offers products and services including NATSpert Kit, Maverick Spin Column-Based Isolation Kit, Compact XL, Compact Q, and Compact DX. NATSpert operates in a competitive market with competitors including Souzhou Ribo Life Science, Senzo, PathoQuest, Hememics Biotechnologies and Quantalife, among others.
- Headquarter Pune, India
- Employees 437 as on 31 Mar, 2022
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mylab Discovery Solutions Pvt. Ltd.
- Jurisdiction Lonawala, Maharashtra, India
-
Annual Revenue
$32.64 M (USD)0as on Mar 31, 2022
-
Net Profit
$1.92 M (USD)0as on Mar 31, 2022
-
EBITDA
$3.63 M (USD)0as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
437
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NATSpert
NATSpert offers a comprehensive portfolio of products and services, including NATSpert Kit, Maverick Spin Column-Based Isolation Kit, Compact XL, Compact Q, and Compact DX.
Multiplex RealTime PCR test for detecting HIV, HBV, and HCV viruses
Kit for isolating DNA using spin column technology
Sample-to-PCR system for efficient molecular lab operations
Fluorescence quantitative PCR detection for up to 16 samples
Sample-to-result system for molecular testing in labs
Funding Insights of NATSpert
Detailed funding history for NATSpert
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NATSpert
Investment portfolio details for NATSpert
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NATSpert
Detailed financials for NATSpert
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Natspert Comparisons
Peer comparison for NATSpert
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NATSpert
NATSpert operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, Senzo, PathoQuest, Hememics Biotechnologies and Quantalife, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Sequencing-based platform for microorganism detection in patients is developed.
|
Detailed competitors of NATSpert
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Natspert
Complete news archive for NATSpert
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NATSpert
NATSpert was founded in 2017.
NATSpert is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
As of Mar 31, 2022, the latest employee count at NATSpert is 437.
Annual revenue of NATSpert is $32.64M as on Mar 31, 2022.
Mylab Discovery Solutions Pvt. Ltd. specializes in developing and commercializing molecular diagnostic tests and instruments for human diagnostics, food safety, agriculture, veterinary medicine, and DNARNA purification. They offer products like NATSpert kits for blood screening and automated systems such as Compact XL for efficient sample processing. Based in Pune, India, they serve labs, hospitals, and blood banks with reliable, automated solutions that ensure high sensitivity and regulatory compliance, empowering users to obtain timely results.
NATSpert's top competitors include Souzhou Ribo Life Science, Quantalife and Senzo.
NATSpert offers NATSpert Kit, Maverick Spin Column-Based Isolation Kit, Compact XL, Compact Q, and Compact DX.